Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:13 PM
Ignite Modification Date:
2025-12-24 @ 10:13 PM
NCT ID:
NCT05812235
Eligibility Criteria:
Inclusion Criteria:
* At least 3 years have elapsed since esophagectomy due to esophageal cancer
* Provide signed informed consent
Exclusion Criteria:
* Current use of the following osteoporosis agents; Teriparatide, Denosumab, and - -
* bisphosphonate
* Present malignancy (except in situ carcinoma)
* Radiotherapy
* Any condition that required chronic (greater than three months cumulative and greater than 5 mg/day) glucocorticoid therapy
* Other diseases which affect bone metabolism Any disorder that, in the opinion of the investigator, may compromise the ability of the subject to give written informed consent and/or comply with study procedures Received \> 3 months (or equivalent) of osteoporosis treatment Currently enrolled in or has not yet completed at least 1 month since ending other investigational device or drug trial(s), or subject is receiving other investigational agent(s).
Healthy Volunteers:
True
Sex:
MALE
Minimum Age:
50 Years
Maximum Age:
90 Years
Study:
NCT05812235
Study Brief:
Protocol Section:
NCT05812235